Prednisone is a synthetic corticosteroid prescribed across a wide range of adult conditions, from asthma flare-ups and rheumatoid arthritis to inflammatory bowel disease and lupus. It works by dialing down the immune system and suppressing inflammation, which makes it remarkably effective in the short term but potentially harmful when used for weeks or months. The drug’s risk profile shifts dramatically depending on dose and duration, and understanding that shift is essential for anyone taking it or considering it.
How Prednisone Works
Prednisone is actually a prodrug, meaning it does not do much on its own. Your liver converts it into its active form, prednisolone, which then goes to work. In people with severe liver disease, that conversion can be significantly impaired. One study found that patients with severely compromised liver function achieved only about half the active prednisolone levels compared to patients with mildly impaired livers after taking the same oral dose of prednisone.1PubMed Central. Impaired conversion of prednisone to prednisolone in patients with liver cirrhosis For people in that situation, doctors sometimes prescribe prednisolone directly instead.
Once activated, prednisolone enters cells and binds to receptors in the cytoplasm. Those receptors then travel to the cell nucleus, where they interfere with the activity of proteins that normally switch on inflammatory genes. The result is a broad shutdown of the inflammatory cascade: fewer immune cells are recruited, less swelling occurs, and the overactive immune response is brought under control.2PubMed. Anti-inflammatory actions of glucocorticoids: molecular mechanisms This mechanism is why prednisone works in so many different diseases. Inflammation is a shared feature of dozens of conditions, and prednisone treats the inflammation itself rather than the underlying cause.
Conditions Prednisone Treats in Adults
The list of adult conditions that prednisone addresses is long, but the major categories are fairly intuitive once you understand that most involve an immune system that is attacking the body’s own tissues or overreacting to a stimulus.
Autoimmune Diseases
Rheumatoid arthritis is one of the most common reasons adults are prescribed prednisone. A randomized trial found that low-dose prednisone produced more clinical improvement than placebo in the first six months of early active rheumatoid arthritis, and patients on prednisone needed fewer additional therapies.3PubMed. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects Lupus is another major indication. In systemic lupus erythematosus, glucocorticoids have traditionally been used both to control acute flares and as ongoing maintenance therapy.4PubMed Central. Steroids in Lupus: Enemies or Allies Other autoimmune conditions commonly managed with prednisone include vasculitis, polymyalgia rheumatica, and certain types of kidney inflammation.
Respiratory Conditions
Short bursts of prednisone are standard treatment for acute asthma attacks, where a few days of oral steroids can stop a dangerous episode of airway narrowing. In chronic obstructive pulmonary disease, systemic corticosteroids are recommended by all major guidelines for treating acute flare-ups. They improve airflow, decrease treatment failure and relapse rates, and can shorten hospital stays. Research has also shown that lower oral doses work about as well as high-dose intravenous regimens while producing fewer side effects, and shorter courses appear as effective as longer ones.5PubMed Central. Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease
Inflammatory Bowel Disease
Corticosteroids remain the go-to option for rapidly controlling acute flares of both Crohn’s disease and ulcerative colitis. However, they do not work for keeping the disease quiet long term, and up to half of patients either fail to respond or relapse when the dose is tapered.6PubMed Central. Using corticosteroids appropriately in inflammatory bowel disease: a guide for primary care That poor track record for maintenance therapy is why gastroenterologists push to transition patients to steroid-sparing medications as quickly as possible.
Other Uses
Prednisone shows up in treatment plans for allergic reactions, certain cancers (particularly lymphomas and leukemias, where it is part of chemotherapy protocols), organ transplant rejection prevention, skin conditions like severe eczema and pemphigus, gout flares, and even some cases of sudden hearing loss. The drug’s breadth of use reflects the fact that inflammation underlies an enormous number of medical problems.
Short-Term Side Effects
Most people who take a brief course of prednisone, say five to fourteen days, get through it without serious problems. Common nuisances during short courses include trouble sleeping, increased appetite, a jittery or wired feeling, mood swings, and stomach upset. These tend to resolve once the drug is stopped.
Rare but documented complications of even short courses include severe mood changes, psychotic reactions, and avascular necrosis (bone death, discussed in more detail below). One review noted that while these events are uncommon and most short courses are problem-free, there have been reports of fatal varicella-zoster infections in otherwise healthy patients taking short-term corticosteroids.7PubMed Central. Side effects of short-term oral corticosteroids The takeaway is that short-term use is generally safe, but “generally safe” is not the same as “risk-free.”
Bone Loss and Osteonecrosis
If there is one long-term risk that drives clinical concern about prednisone, it is what the drug does to bones. Glucocorticoids interfere with the cells that build new bone and tip the balance toward the cells that break it down. They also disrupt the blood supply within bone tissue, which impairs repair and further weakens the skeleton.8PubMed Central. Understanding and Managing Corticosteroid-Induced Osteoporosis This bone loss starts fast. Even low-dose prednisone rapidly decreases markers of bone formation in studies of postmenopausal women, though the changes partially reversed after the drug was stopped.9PubMed. Effects of low-dose prednisone on bone metabolism
Because of this risk, doctors typically recommend calcium, vitamin D, and sometimes bone-protective medications for anyone expected to take prednisone for more than a few months. Weight-bearing exercise also helps counteract the muscle weakness that glucocorticoids cause, which itself contributes to fracture risk by reducing the protective support around bones.
Osteonecrosis, sometimes called avascular necrosis, is a separate and more dramatic bone complication. It happens when blood flow to a section of bone, most often the hip, is cut off and the bone tissue dies. Corticosteroid use is the most commonly identified cause of this condition.10PubMed. Relationship between systemic corticosteroids and osteonecrosis A meta-analysis found that patients taking doses above 20 mg per day had roughly nine times the odds of developing osteonecrosis compared to those on lower doses, and every additional 10 mg per day increased the rate by about 3.6 percentage points.11The Journal of Arthroplasty. Efficacy of Varying Corticosteroid Regimens on Osteonecrosis Incidence: A Meta-Analysis and Systematic Literature Review That said, case reports exist of osteonecrosis developing on doses as low as 5 mg per day used for a few years, so low dose does not mean zero risk.12PubMed Central. Avascular necrosis of the femoral head due to low-dose corticosteroid used in a patient with panhypopituitarism: A case report and literature review
Blood Sugar, Weight, and Metabolic Changes
Prednisone is notorious for raising blood glucose. Hyperglycemia is one of the most common side effects of glucocorticoid therapy, and people who already have diabetes or prediabetes are at the highest risk of clinically significant blood sugar spikes.13PubMed Central. Steroid hyperglycemia: Prevalence, early detection and therapeutic recommendations: A narrative review Even people with perfectly normal glucose levels before starting prednisone can develop what is sometimes called “steroid diabetes” during treatment, particularly at higher doses. If you are on prednisone for more than a week or two, your doctor will likely monitor your blood sugar, especially if you have other risk factors for diabetes.
Weight gain is the side effect patients complain about most. Prednisone increases appetite and promotes fat redistribution, typically toward the face (the classic “moon face”), the back of the neck, and the abdomen. This pattern differs from ordinary weight gain and can be distressing. Fluid retention from sodium shifts adds to the effect. These metabolic changes are largely dose- and duration-dependent and tend to reverse, at least partially, after the drug is stopped, though the process can be slow.
Infection Risk
Because prednisone suppresses the immune system, it increases vulnerability to infections, and it can make existing infections harder for your body to control. The concern is greatest at higher doses and longer durations. One area that gets particular attention is tuberculosis. A study of patients with rheumatic diseases found that those on high-dose glucocorticoids, defined as more than 15 mg daily, had significantly higher rates of latent tuberculosis reactivating into active disease. Researchers recommended screening and preventive treatment for latent tuberculosis in patients receiving that dose level for more than four weeks.14PubMed. High risk of activation of latent tuberculosis infection in rheumatic disease patients
Beyond tuberculosis, prednisone raises the risk of fungal infections, herpes virus reactivation, and ordinary bacterial infections. People on long-term corticosteroids are sometimes advised to get pneumonia and influenza vaccines before starting treatment and to avoid close contact with anyone who has chickenpox or measles, since those viral infections can become life-threatening when the immune system is suppressed.
Eye Problems
Two eye conditions are linked to corticosteroid use: cataracts and glaucoma. The connection between long-term systemic steroids and increased eye pressure was first reported in the 1950s, and both complications remain well-recognized today.15PubMed Central. Steroid-induced Glaucoma: An Avoidable Irreversible Blindness Steroid-induced glaucoma can cause irreversible vision loss if it goes undetected, which is why patients on prolonged corticosteroid therapy are often referred for regular eye pressure checks. Cataracts from steroids tend to form in the back of the lens and may develop insidiously over months to years of use. The risk increases with cumulative dose.
Mental Health Effects
Prednisone can alter mood, cognition, and behavior in ways that range from mild to severe. At the mild end, many patients report feeling irritable, anxious, or emotionally volatile. Sleep disruption is extremely common and can worsen mood changes on its own. At the severe end, some patients develop full psychiatric syndromes including mania, depression, and psychosis.16Mayo Clinic Proceedings. Psychiatric Adverse Effects of Corticosteroids These psychiatric effects are often underappreciated by both patients and prescribers.17PubMed Central. Corticosteroid-Induced Psychiatric Disorders: Mechanisms, Outcomes, and Clinical Implications
A practical point worth knowing: psychiatric side effects are more common at doses above 40 mg per day, but they can appear at any dose. They can also emerge days to weeks into treatment rather than immediately. If you or someone you know develops unusual mood changes, racing thoughts, or paranoid thinking while on prednisone, it is worth contacting a doctor rather than assuming the feelings are unrelated to the medication. These symptoms almost always resolve when the drug is tapered or stopped.
Skin and Wound Healing
Long-term prednisone use thins the skin, makes it bruise more easily, and causes stretch marks. It also impairs wound healing, which matters if you need surgery. Research found that patients on chronic corticosteroids for at least 30 days before surgery had wound complication rates two to five times higher than non-users. Interestingly, high-dose corticosteroid use for fewer than ten days did not appear to meaningfully affect wound healing.18PubMed Central. Corticosteroids and wound healing: clinical considerations in the perioperative period The distinction between chronic and short-term use matters here. If you need surgery and you have been on prednisone long-term, your surgeon should know about it.
Why You Cannot Just Stop Taking Prednisone
One of the most important things to understand about prednisone is that stopping abruptly after prolonged use can be dangerous. Your adrenal glands normally produce cortisol, a hormone that prednisone mimics. When you take prednisone for an extended period, your body’s own cortisol production shuts down because the drug is doing that job. Prolonged glucocorticoid use suppresses the signals from the brain to the adrenal glands, and those glands can actually shrink from disuse.19PubMed Central. Impact of glucocorticoid therapy on hypothalamic-pituitary-adrenal axis function in pediatric nephrotic syndrome: A narrative review
If you stop the drug suddenly, your body has no cortisol of its own to fall back on. This can lead to adrenal insufficiency, which causes fatigue, weakness, nausea, low blood pressure, and in severe cases can be life-threatening. The solution is tapering: gradually reducing the dose to give the adrenal glands time to wake back up. For people who have been on prednisone for less than three to four weeks, stopping abruptly is usually safe. Beyond that window, a gradual taper is standard practice.20PubMed Central. Practical guidance for stopping glucocorticoids
The taper itself follows a general pattern. Higher doses can be reduced more quickly as long as the underlying disease does not flare. Once you approach the body’s normal physiological range, around 5 to 7.5 mg per day of prednisone, the reductions become smaller and slower to allow the adrenal glands to resume their normal function.21PubMed Central. The Glucocorticoid Taper: A Primer for the Clinicians Some people breeze through a taper in a few weeks. Others, particularly those who have been on higher doses for months, may need a taper that stretches over many months.
When Timing the Dose Matters
Most people take prednisone in the morning, and there is a pharmacological reason for that. Your body’s own cortisol peaks in the early morning hours, so taking the drug around that time mimics the natural rhythm and tends to cause less disruption to sleep and less suppression of the adrenal glands. Research on prednisolone found that the drug’s effects on cortisol suppression and immune cell changes depend heavily on when it is taken, with morning dosing within a therapeutic dose range producing less cumulative cortisol suppression than other timings.22PubMed Central. Assessment of the impact of dosing time on the pharmacokinetics/pharmacodynamics of prednisolone
For rheumatoid arthritis specifically, a modified-release version of prednisone has been developed that is taken at bedtime but releases the drug around 2 a.m., targeting the nocturnal inflammatory surge that causes severe morning stiffness. Trials found that this approach reduced morning stiffness and fatigue beyond what conventional morning prednisone achieved, without additional suppression of adrenal function or a worse safety profile.23Rheumatology. Glucocorticoids and chronotherapy in rheumatoid arthritis This is a niche application, but it illustrates a broader point: the same drug at the same dose can behave quite differently depending on when you take it.
Steroid-Sparing Strategies
Given prednisone’s long list of potential harms, a central goal in modern treatment of chronic inflammatory diseases is to use as little of it as possible for as short a time as possible. The term “steroid-sparing” describes medications that allow doctors to reduce or eliminate prednisone while still controlling the disease.
Older steroid-sparing drugs include azathioprine, methotrexate, and cyclophosphamide. These immunosuppressants have their own side effect profiles, but they allow long-term disease control without the cumulative damage of chronic prednisone. More recently, biologic therapies approved for lupus, including belimumab and anifrolumab, have demonstrated clear steroid-sparing effects in clinical trials.24PubMed Central. Assessing the steroid-sparing effect of biological agents in randomized controlled trials for lupus: a scoping review These drugs target specific parts of the immune system rather than suppressing it broadly, which in principle should mean fewer off-target effects. The practical result is that many patients with lupus, rheumatoid arthritis, and inflammatory bowel disease can now be managed with less prednisone than was typical a generation ago, or without it entirely after an initial course.25Lupus Science & Medicine. Optimizing steroid-sparing drugs in SLE
In inflammatory bowel disease, the push toward steroid-sparing therapy is especially urgent. As noted earlier, up to half of patients either do not respond to corticosteroids or relapse during tapering, and the drugs are ineffective for maintaining remission.6PubMed Central. Using corticosteroids appropriately in inflammatory bowel disease: a guide for primary care Biologic agents and immunomodulators have become the backbone of long-term management for moderate-to-severe cases, with prednisone reserved for bridging therapy during flares.
Prednisone in Older Adults
Older adults face a compounded version of nearly every prednisone risk. They already have lower bone density on average, so glucocorticoid-induced bone loss hits harder and leads to fractures more readily. Their skin is thinner, their glucose regulation less robust, and their immune defenses are already declining with age. The psychiatric effects can be mistaken for dementia or delirium, delaying recognition that the drug is the problem.
Despite these heightened risks, older adults are among the most frequent users of prednisone, often for conditions like polymyalgia rheumatica and giant cell arteritis, where corticosteroids remain the first-line treatment and alternatives are limited. Clinicians managing these patients tend to be more aggressive about bone protection, blood sugar monitoring, and reaching the lowest effective dose as quickly as possible. If you are over 65 and prescribed prednisone, it is reasonable to ask about a bone density scan, whether calcium and vitamin D supplementation is appropriate, and what the plan is for getting off the drug or reaching the lowest possible dose.